The economic impact of ME/CFS: individual and societal costs
about
Biopersistence and brain translocation of aluminum adjuvants of vaccinesAbsence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United StatesSystems biology of complex symptom profiles: capturing interactivity across behavior, brain and immune regulationA Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?Association of catastrophizing and fatigue: a systematic reviewIllness progression in chronic fatigue syndrome: a shifting immune baselineTracking post-infectious fatigue in clinic using routine Lab testsThe hidden cost of chronic fatigue to patients and their families.Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndromeDietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review.XMRV and Public Health: The Retroviral Genome Is Not a Suitable Template for Diagnostic PCR, and Its Association with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Appears Unreliable.Economic evaluation of multidisciplinary rehabilitation treatment versus cognitive behavioural therapy for patients with chronic fatigue syndrome: A randomized controlled trialClinical features of outpatients with somatization symptoms treated at a Japanese psychosomatic medicine clinic.The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carersEvidence for a heritable predisposition to Chronic Fatigue Syndrome.Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care.The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME national outcomes databaseA formal analysis of cytokine networks in chronic fatigue syndrome.Minimum data elements for research reports on CFSAntibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).Investigating unexplained fatigue in general practice with a particular focus on CFS/ME.The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs.The impact of energy modulation on physical functioning and fatigue severity among patients with ME/CFSImmunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.Chronic Fatigue Syndrome and Myalgic Encephalomyelitis: Toward An Empirical Case Definition.Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).A multicenter blinded analysis indicates no association between chronic fatigue syndrome/myalgic encephalomyelitis and either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virusCytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue.An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder.The use of mixed methods in studying a chronic illnessDaily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathologyNeuromuscular strain as a contributor to cognitive and other symptoms in chronic fatigue syndrome: hypothesis and conceptual model.Myalgic encephalomyelitis/chronic fatigue syndrome patients' reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys.Role of dietary modification in alleviating chronic fatigue syndrome symptoms: a systematic review.Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.Telephone-administered versus live group cognitive behavioral stress management for adults with CFS.Mortality in Patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome.
P2860
Q21129422-CC92889B-D859-4748-A7D9-49E335697BCDQ24604178-A6B408A4-FD39-4E22-B570-8B2342151B5FQ24630573-2C9B6A67-B6C2-4058-BF9F-32ACCD8718F8Q26747503-F0737F31-F818-414A-BF10-FAD187B3600FQ26851778-7FCE6DF9-2BEB-4770-8DA8-7501232917DBQ28389279-5423780B-A397-480F-B528-5C6721F7FAF9Q28393209-021C1DB3-0A9E-43F9-BEBC-9660D617EB8AQ33536847-3BA6E5E5-FDED-400E-89B8-A0E997E60FF7Q33593176-D2B07480-A958-4885-AAC1-910F3126B7B0Q33604317-BADDDD43-C4B8-44BD-8184-D59809EA595FQ33697812-AE0F144F-A3F3-44B7-AD7D-B57DF0C896F8Q33711512-2C492970-68BB-4CF3-A2FC-4C177EC39FA8Q33757366-0674FB6A-A76A-409D-A303-D576060419BDQ33846424-128D623B-F1FF-4ECE-A882-5ED704DAD9A7Q33914325-9A69B6B9-C169-41E4-B6E5-D23F72D67933Q33914379-158125D5-1840-4A3E-BB8E-77D241234EA8Q33973102-BBACCD0D-5CBF-4792-94FC-7E79EB7178B6Q34020886-3B33CAB0-DFF2-4A62-B801-DB9276365F9DQ34126219-0BC2E20B-78A4-4C74-B38C-4AC5742DE303Q34151020-A8C6A56A-8D39-4C6A-BFCA-D737BB436163Q34478959-686B81D0-2668-4669-A3EF-ACC33981032BQ34520840-DB1EC969-8B95-4B98-BFA1-1C6BE1AD9A00Q34534644-6CA86ECF-CA29-469B-90E2-120EA77B454FQ34552614-4FE7E4C6-750D-4A68-AF13-6B6299E4D21AQ34974813-7F8D53D6-4E28-4E41-9C1C-E6FAA0B028B1Q35061216-B2776A0E-D6DA-4A3B-AA2C-5FA1C2B7EFA3Q35647193-F2363C84-1C32-42AE-84F3-E69FBFA52142Q35788478-BCAB185F-F98B-4F6C-9681-013990510235Q35873043-1A34EA5E-4A4B-4767-A758-553DB4D2738BQ36250588-CE6F9401-FEEA-48CF-B193-BEA3C66F5B2CQ36346397-BB117C88-8B04-46F9-B39E-F95FF419FC9BQ36626916-B65B38F4-E82C-4B52-BA67-3FD71098B5D6Q36798173-02EABF20-E32A-4136-8F9E-E2952DD4B743Q36798494-547AF65E-CC7F-4A05-B997-909E899C4BCBQ36847728-C4E2BDFB-CBEA-4C4D-82E8-F7D17B91761BQ38605498-C176A77A-70DC-495B-B0B1-FF9EECD72553Q38724831-8AAE5E9E-B992-4901-8627-4E0D0AD3804CQ38740396-A094C1A9-8E32-455B-9B4D-D4D17D322939Q38767944-F16B479B-38B7-46FC-BDC2-F2EA9F23F63CQ39030257-D4FC1FDB-F8F2-47C3-9BF6-C32643086360
P2860
The economic impact of ME/CFS: individual and societal costs
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The economic impact of ME/CFS: individual and societal costs
@ast
The economic impact of ME/CFS: individual and societal costs
@en
The economic impact of ME/CFS: individual and societal costs
@en-gb
The economic impact of ME/CFS: individual and societal costs
@nl
type
label
The economic impact of ME/CFS: individual and societal costs
@ast
The economic impact of ME/CFS: individual and societal costs
@en
The economic impact of ME/CFS: individual and societal costs
@en-gb
The economic impact of ME/CFS: individual and societal costs
@nl
altLabel
The Economic impact of ME/CFS: Individual and societal costs
@en
prefLabel
The economic impact of ME/CFS: individual and societal costs
@ast
The economic impact of ME/CFS: individual and societal costs
@en
The economic impact of ME/CFS: individual and societal costs
@en-gb
The economic impact of ME/CFS: individual and societal costs
@nl
P2093
P2860
P3181
P356
P1476
The economic impact of ME/CFS: individual and societal costs
@en
P2093
Abra Johnson
Leonard A Jason
Lisa Valentine
Mary C Benton
Susan Torres-Harding
P2860
P2888
P3181
P356
10.1186/1476-5918-7-6
P407
P577
2008-01-01T00:00:00Z
P5875
P6179
1033376274